Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adhesion G protein-coupled receptor G5 (ADGRG5, also known as GPR114) is an orphan GPCR of the adhesion subfamily distinguished by a large N-terminal extracellular region containing adhesion modules and a conserved GPCR-Autoproteolysis INducing (GAIN) domain. Its main function is transmembrane signal transduction via Gs protein coupling, resulting in adenylate cyclase activation and increased cAMP levels. ADGRG5 is highly expressed in immune cells such as eosinophils and lymphocytes, implicating roles in immune regulation and inflammation. Alternative splicing and unique structural features provide cell-type-specific functional diversity. Drug discovery efforts have identified small molecules (e.g., dihydromunduletone) capable of antagonizing its activation mechanism, and the receptor is a promising but underexplored therapeutic target for inflammatory diseases, cancer, and other disorders.
Small molecule antagonists can block tethered peptide agonist activation Synthetic peptides can mimic or antagonize the tethered agonist mechanism, activating or inhibiting the receptor
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adhesion G protein-coupled receptor G5 (ADGRG5 (also commonly referred to as GPR114)).